Treatment for Perioral Dermatitis
The first-line treatment for perioral dermatitis is oral tetracyclines for adults, while topical metronidazole, erythromycin, or pimecrolimus are recommended for children or milder cases, with immediate discontinuation of any topical corticosteroids being essential for all patients. 1, 2
Initial Management
- Discontinue all topical corticosteroids immediately ("zero therapy"), as they are often the causative agent and can worsen the condition long-term despite initial improvement 1, 3
- Remove potential irritants including cosmetics, facial soaps, and other skincare products that may exacerbate the condition 4
- Use gentle, non-irritating soap substitutes for cleansing the affected areas 4
- Apply emollients regularly to maintain skin hydration and repair the skin barrier 4
Treatment Algorithm
For Adults:
First-line therapy:
Topical options:
For Children (under 8 years):
First-line therapy:
Systemic options (if topical therapy fails):
Special Considerations
- For steroid-induced perioral dermatitis, expect a temporary worsening of symptoms (rebound phenomenon) after discontinuation of topical steroids 3
- In mild cases, "zero therapy" alone (discontinuation of all facial products) may be sufficient for resolution, though it takes longer than active treatment 2
- For severe or refractory cases, consider systemic isotretinoin as a last resort 3
- Avoid high-potency topical steroids in the facial region due to increased absorption and risk of skin atrophy 4
Duration of Treatment
- Continue oral antibiotics until complete resolution is achieved (typically 4-8 weeks) 1, 3
- For topical treatments, continue for 1-2 weeks after clinical clearance to prevent relapse 4
- Monitor for signs of skin atrophy, striae, or secondary infection during treatment 4
Common Pitfalls to Avoid
- Using topical corticosteroids to treat perioral dermatitis (they may provide temporary relief but worsen the condition long-term) 7
- Failing to identify and eliminate potential irritants that may be contributing to the condition 4
- Discontinuing treatment too early before complete resolution, which may lead to relapse 3
- Not warning patients about the initial worsening that may occur after discontinuing topical steroids 3